Target intelligence / Profile preview

Phospholipid scramblase 3 (PLSCR3)

Target
PLSCR3
Molecular classification
Enzyme, Membrane protein, Lipid transporter, Transcription regulator (Tubby-like protein superfamily member)
01

Overview

Phospholipid scramblase 3 (PLSCR3) is an ATP-independent, calcium-induced enzyme responsible for rapid bidirectional transport ("scrambling") of specific mitochondrial phospholipids, primarily cardiolipin, across mitochondrial membranes. This activity is critical for mitochondrial membrane organization, the apoptotic release of cytochrome c, and amplification of apoptotic signaling. PLSCR3 also modulates adipocyte differentiation as a negative regulator, and knockout models in mice reveal its essential role in preventing obesity, insulin resistance, and lipid accumulation. PLSCR3 belongs to both the scramblase family and the Tubby-like superfamily of transcription regulators. Though central to apoptosis and metabolic homeostasis, drug development targeting PLSCR3 remains unestablished, and the protein plays pleiotropic roles in cell signaling and transcriptional regulation.

Other names
Phospholipid scramblase 3PLSCR3PL scramblase 3Ca(2+)-dependent phospholipid scramblase 3Scr3
02

Biological functions

Phospholipid scrambling (bidirectional, non-specific translocation of mitochondrial membrane lipids)Regulation of mitochondrial apoptosis via redistribution of cardiolipinRegulation of cytochrome c release from mitochondriaNegative regulator of adipogenesisModulation of mitochondrial respiratory function and morphology
03

Disease associations

Metabolic syndrome (obesity, insulin resistance, dyslipidemia)Barth syndrome3-Methylglutaconic aciduriaPossibly other mitochondrial and metabolic disorders
04

Safety considerations

Loss of PLSCR3 function may promote metabolic syndrome, obesity, insulin resistance, and dyslipidemiaPotential challenges targeting PLSCR3 therapeutically due to its broad physiological roles in apoptosis and metabolism

Beyond the preview

Go deeper on Phospholipid scramblase 3 (PLSCR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipid scramblase 3 (PLSCR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call